[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.201.14. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
May 27, 1983

Airway Constriction in Normal Humans Produced by Inhalation of Leukotriene D: Potency, Time Course, and Effect of Aspirin Therapy

Author Affiliations

From the Department of Medicine, Harvard Medical School (Drs Weiss, Drazen, McFadden, Weller, Lewis, and Austen), the Departments of Medicine (Drs Drazen and McFadden) and Rheumatology and Immunology (Drs Lewis and Austen), Brigham and Women's Hospital, the Department of Medicine, Beth Israel Hospital (Drs Weiss and Weller), and the Shipley Institute of Medicine (Dr McFadden), Boston; and the Department of Chemistry, Harvard University, Cambridge, Mass (Dr Corey).

JAMA. 1983;249(20):2814-2817. doi:10.1001/jama.1983.03330440052033
Abstract

Five normal human subjects inhaled aerosols generated from solutions of leukotriene D (LTD) to determine the bronchoconstrictor potency and the time course of airway obstruction produced by this constituent of slow-reacting substance of anaphylaxis. The dose-effect and time-effect curves were compared with curves similarly generated for the well-characterized airway constrictor histamine. Leukotriene D was, on average, 5,900 times more potent than histamine on a molar basis in producing an identical decrement in maximal expiratory flow rate at 30% of control vital capacity above residual volume. In addition, although LTD had a rapid onset of effect, similar to that of histamine, the airway obstruction produced by LTD was longer lasting, thereby reflecting more closely the response of asthmatic allergic individuals to antigen inhalation. The response of these subjects to inhalation of LTD was not altered by ingestion of aspirin, suggesting that the airway obstruction was not mediated by cyclooxygenase products of arachidonic acid.

(JAMA 1983;249:2814-2817)

×